The Injective price has increased by 5% to trade at $3.23 following its recent network approval of its IIP-619 proposal.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results